Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callawa CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American heart association. Circulation. 2019;139(10):e56–528.
Article
PubMed
Google Scholar
Dini FL, Bajraktari G, Zara C, Mumoli N, Rosa GM. Optimizing management of heart failure by using echo and natriuretic peptides in the outpatient unit. Adv Exp Med Biol. 2018;1067:145–59.
Article
PubMed
Google Scholar
Albuquerque de Almeida F, Al M, Koymans R, Caliskan K, Kerstens A, Severens JL. Early warning systems for the management of chronic heart failure: a systematic literature review of cost-effectiveness models. Expert Rev Pharmacoecon Outcomes Res. 2018;18(2):161–75.
Article
PubMed
Google Scholar
Desai A. Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation. 2008;118(16):1609–11.
Article
PubMed
Google Scholar
von Lueder TG, Krum H. New medical therapies for heart failure. Nat Rev Cardiol. 2015;12(12):730–40.
Article
CAS
Google Scholar
Wen JX, Wang J, Li PY, Wang RL, Wang JB, Zhou XL, et al. Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms. Biomed Pharmacother. 2019;115:108881.
Article
CAS
PubMed
Google Scholar
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu JD, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457(7231):910–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455(7216):1054–6.
Article
CAS
PubMed
Google Scholar
Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature. 2006;440(7087):1073–7.
Article
CAS
PubMed
Google Scholar
Wei SZ, Qian LQ, Niu M, Liu HH, Yang YX, Wang YY, et al. The modulatory properties of Li-Ru-Kang treatment on hyperplasia of mammary glands using an integrated approach. Front Pharmacol. 2018;9:651.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ji H, Liu Y, He F, An R, Du Z. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats. J Pharm Biomed Anal. 2018;156:104–15.
Article
CAS
PubMed
Google Scholar
Yang YX, Li FY, Wei SZ, Liu XY, Wang YY, Liu HH, et al. Metabolomics profiling in a mouse model reveals protective effect of Sancao granule on Con A-Induced liver injury. J Ethnopharmacol. 2019;238:111838.
Article
CAS
PubMed
Google Scholar
Wen JX, Li RS, Wang J, Hao JJ, Qin WH, Yang T, et al. Therapeutic effects of Aconiti Lateralis Radix Praeparata combined with Zingiberis Rhizoma on doxorubicin-induced chronic heart failure in rats based on an integrated approach. J Pharm Pharmacol. 2020;72(2):279–93.
Article
CAS
PubMed
Google Scholar
Bai Y, Chen Q, Sun YP, Wang X, Lv L, Zhang LP, et al. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation. Cardiovasc Ther. 2017. https://doi.org/10.1111/1755-5922.12277.
Article
PubMed
Google Scholar
Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation. 1994;89(6):2829–35.
Article
CAS
PubMed
Google Scholar
Wen JX, Zou WJ, Wang RL, Liu HH, Yang YX, Li HT, et al. Cardioprotective effects of Aconiti Lateralis Radix Praeparata combined with Zingiberis Rhizoma on doxorubicin-induced chronic heart failure in rats and potential mechanisms. J Ethnopharmacol. 2019;238:111880.
Article
CAS
PubMed
Google Scholar
Zhang L, Lu XH, Wang JB, Li PY, Li HT, Wei SZ, et al. Zingiberis rhizoma mediated enhancement of the pharmacological effect of aconiti lateralis radix praeparata against acute heart failure and the underlying biological mechanisms. Biomed Pharmacother. 2017;96:246–55.
Article
CAS
PubMed
Google Scholar
Wen JX, Zhang L, Liu HH, Wang JB, Li JY, Yang YX, et al. Salsolinol has effect on attenuating doxorubicin-induced chronic heart failure in rats and improving mitochondrial function in H9c2 cardiomyocytes. Fron Pharmacol. 2019;10:1135.
Article
CAS
Google Scholar
Lu X, Zhang L, Li PY, Wang JB, Li RS, Huang YQ, et al. The protective effects of compatibility of Aconiti Lateralis Radix Praeparata and Zingiberis Rhizoma on rats with heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α pathway. Biomed Pharmacother. 2017;92:651–60.
Article
CAS
PubMed
Google Scholar
Wen JX, Zhang L, Wang J, Wang JB, Wang LF, Wang RL, et al. Therapeutic effects of higenamine combined with [6]-gingerol on chronic heart failure induced by doxorubicin via ameliorating mitochondrial function. J Cell Mol Med. 2020;24(7):4036–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chong J, Wishart DS, Xia J. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis. Curr Protoc Bioinformatics. 2019;68(1):e86.
Article
PubMed
Google Scholar
Murray JD, Moussavi-Harami F, Regnier M. The effect of ribonucleotide reductase overexpression on cardiomyocyte metabolism. Biophys J. 2017;112(3):424a.
Article
Google Scholar
Heggermont WA, Papageorgiou AP, Heymans S, van Bilsen M. Metabolic support for the heart: complementary therapy for heart failure? Eur J Heart Fail. 2016;18(12):1420–9.
Article
PubMed
Google Scholar
Fillmore N, Lopaschuk GD. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim Biophys Acta. 2013;1833(4):857–65.
Article
CAS
PubMed
Google Scholar
Takahiro M, Natsue K, Miharu U, Hiroaki K, Masahisa H, Yuichi K. Effects of L-carnitine on propofol-induced inhibition of free fatty acid metabolism in fasted rats and in vitro. Open J Anesthesiol. 2018;8(5):147–58.
Article
Google Scholar
Dolinsky VW. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction. Biol Chem. 2017;398(9):955–74.
Article
CAS
PubMed
Google Scholar
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol. 2016;69(12):1167.
Article
PubMed
Google Scholar
Zhang L, Wei TT, Li Y, Li J, Fan Y, Huang FQ, et al. Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases. Circulation. 2018;137(13):1374–90.
Article
CAS
PubMed
Google Scholar
Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization. Eur J Heart Fail. 2005;7(4):618–23.
Article
CAS
PubMed
Google Scholar
Fukushima A, Milner K, Gupta A, Lopaschuk GD. Myocardial energy substrate metabolism in heart failure: from pathways to therapeutic targets. Curr Pharm Des. 2015;21(25):3654–64.
Article
CAS
PubMed
Google Scholar
Yang Y, Zhang H, Li X, Yang T, Jiang Q. Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro. Int J Clin Exp Pathol. 2015;8(10):12216–24.
CAS
PubMed
PubMed Central
Google Scholar
Whicher A, Camprubi E, Pinna S, Herschy B, Lane N. Acetyl phosphate as a primordial energy currency at the origin of life. Orig Life Evol Biosph. 2018;48(2):159–79.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen YP, Tsai CW, Shen CY, Day CH, Yeh YL, Chen RJ, et al. Palmitic acid interferes with energy metabolism balance by adversely switching the SIRT1-CD36-fatty acid pathway to the PKC zeta-GLUT4-glucose pathway in cardiomyoblasts. J Nutr Biochem. 2016;31:137–49.
Article
CAS
PubMed
Google Scholar
Leroy C, Tricot S, Lacour B, Grynberg A. Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes. Biochim Biophys Acta. 2008;1781(11–12):685–93.
Article
CAS
PubMed
Google Scholar
Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease. Circ Res. 2007;100(4):474–88.
Article
CAS
PubMed
Google Scholar
Miller EJ, Li J, Leng L, McDonald C, Atsumi T, Bucala R, et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature. 2008;451(7178):578–82.
Article
CAS
PubMed
Google Scholar
Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA. 2008;105(12):4826–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee YS, Kang YJ, Kim HJ, Park MK, Seo HG, Lee JH, et al. Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis. 2006;11(7):1091–100.
Article
CAS
PubMed
Google Scholar
Liu C, Zhu C, Wang G, Xu R, Zhu Y. Higenamine regulates Nrf2-HO-1-Hmgb1 axis and attenuates intestinal ischemia-reperfusion injury in mice. Inflamm Res. 2015;64(6):395–403.
Article
PubMed
CAS
Google Scholar
Wu MP, Zhang YS, Zhou QM, Xiong J, Dong YR, Yan C. Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway. Pharmacol Res. 2016;104:115–23.
Article
CAS
PubMed
Google Scholar
Kosuge T, Yokota M. Letter: Studies on cardiac principle of aconite root. Chem Pharm Bull (Tokyo). 1976;24(1):176–8.
Article
CAS
Google Scholar
Kimura I, Makino M, Takamura Y, Islam MA, Kimura M. Positive chronotropic and inotropic effects of higenamine and its enhancing action on the aconitine-induced tachyarrhythmia in isolated murine atria. Jpn J Pharmacol. 1994;66(1):75–80.
Article
CAS
PubMed
Google Scholar
Liu Q, Liu JJ, Guo HL, Sun SN, Wang SF, Zhang YL, et al. [6]-Gingerol: a novel AT1 antagonist for the treatment of cardiovascular disease. Planta Med. 2013;79(5):322–6.
Article
CAS
PubMed
Google Scholar